Cornerstone Capital Management Holdings’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q2
Sell
-2,400
Closed -$234K 1552
2015
Q1
$234K Buy
2,400
+300
+14% +$29.3K ﹤0.01% 1155
2014
Q4
$195K Buy
2,100
+700
+50% +$65K ﹤0.01% 1095
2014
Q3
$96K Buy
+1,400
New +$96K ﹤0.01% 1178